Neuroprotective agents Bibliography of free accessible medical and biological reviews

Nr.	Year OPEN	Title	rate good	rate bad	no link	Citation
1	2009	The neurotrophic and neuroprotective effects of psychotropic agents.	+	-	nl	Dialogues Clin Neurosci 11(3):333-48 (2009)
2	2007	Neuroprotective effects of propofol in acute cerebral injury.	+	-	nl	CNS Drug Rev 13(3):333-51 (2007)
3	2007	Pharmacological properties of BN82451: a novel multitargeting neuroprotective agent.	+	-	nl	CNS Drug Rev 13(3):317-32 (2007)
4	2001	Gacyclidine: a new neuroprotective agent acting at the N-methyl-D-aspartate receptor.	+	-	nl	CNS Drug Rev 7(2):172-98 (2001)
5	2007	Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain.	+	-	nl	J Cereb Blood Flow Metab 27(6):1108-28 (2007)
6	2002	Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades.	+	-	nl	J Cereb Blood Flow Metab 22(5):503-14 (2002)
7	2001	Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs.	+	-	nl	J Cereb Blood Flow Metab 21(9):1013-33 (2001)
8	2000	Estrogen as a neuroprotectant in stroke.	+	-	nl	J Cereb Blood Flow Metab 20(4):631-52 (2000)
9	2009	Neuroprotective role of mitochondrial uncoupling protein 2 in cerebral stroke.	+	-	nl	J Cereb Blood Flow Metab 29(6):1069-78 (2009)
10	2003	Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. a review.	+	-	nl	Neurotox Res 5(6):375-83 (2003)
11	1990	Brain protection: physiological and pharmacological considerations. Part II: The pharmacology of brain protection.	+	-	nl	Can J Anaesth 37(7):762-77 (1990)
12	2006	Triflusal: an antiplatelet drug with a neuroprotective effect?	+	-	nl	Cardiovasc Drug Rev 24(1):11-24 (2006)
13	2008	Progesterone for the treatment of experimental brain injury; a systematic review.	+	-	nl	Brain 131(Pt 2):318-28 (2008)
14	2002	Neuroprotective effects of antidepressant and mood stabilizing drugs.	+	-	nl	J Psychiatry Neurosci 27(1):8-9 (2002)
15	2004	Neuroprotection and acute spinal cord injury: a reappraisal.	+	-	nl	NeuroRx 1(1):80-100 (2004)
16	2004	Critical appraisal of neuroprotection trials in head injury: what have we learned?	+	-	nl	NeuroRx 1(1):71-9 (2004)
17	2004	Mechanisms of neural cell death: implications for development of neuroprotective treatment strategies.	+	-	nl	NeuroRx 1(1):5-16 (2004)
18	2009	Current status of neuroprotection for cerebral ischemia: synoptic overview.	+	-	nl	Stroke 40(3 Suppl):S111-4 (2009)
19	2001	Neuronal cell death in nervous system development, disease, and injury (Review).	+	-	nl	Int J Mol Med 7(5):455-78 (2001)
20	2010	Novel neuroprotective strategies in ischemic retinal lesions.	+	-	nl	Int J Mol Sci 11(2):544-61 (2010)
21	2009	Unconventional neurotransmitters, neurodegeneration and neuroprotection.	+	-	nl	Braz J Med Biol Res 42(1):68-75 (2009)
22	2004	The search for neuroprotective strategies in stroke.	+	-	nl	AJNR Am J Neuroradiol 25(2):181-94 (2004)
23	2010	Mitochondrial mechanisms of estrogen neuroprotection.	+	-	nl	Biochim Biophys Acta 1800(10):1113-20 (2010)
24	2007	Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system.	+	-	nl	Endocr Rev 28(4):387-439 (2007)
25	2008	Mitochondria, oxidative stress and PARP-1 network: a new target for neuroprotective effects of tetracyclines?	+	-	nl	J Physiol 586(10):2427-8 (2008)
26	2011	Neuropsychotoxic and neuroprotective potentials of dextromethorphan and its analogs.	+	-	nl	J Pharmacol Sci 116(2):137-48 (2011)
27	2008	Neuropsychotoxicity of abused drugs: potential of dextromethorphan and novel neuroprotective analogs of dextromethorphan with improved safety profiles in terms of abuse and neuroprotective effects.	+	-	nl	J Pharmacol Sci 106(1):22-7 (2008)
28	2010	The endocannabinoid system as a target for the treatment of neurodegenerative disease.	+	-	nl	Br J Pharmacol 160(3):480-98 (2010) Scotter EL
29	2010	Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection.	+	-	nl	Br J Pharmacol 159(3):495-501 (2010)
30	2009	IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions.	+	-	nl	Br J Pharmacol 157(6):881-91 (2009)
31	2008	Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly.	+	-	nl	Br J Pharmacol 153 Suppl 1(-):S325-38 (2008)
32	2006	Endogenous neuroprotective factors: neurosteroids.	+	-	nl	Pharmacol Rep 58(3):335-40 (2006)
33	2011	Role of vinpocetine in cerebrovascular diseases.	+	-	nl	Pharmacol Rep 63(3):618-28 (2011)
34	2005	Neuroprotective potential of three neuropeptides PACAP, VIP and PHI.	+	-	nl	Pharmacol Rep 57(3):307-20 (2005)
35	2011	The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease.	+	-	nl	Int J Mol Sci 12(1):506-69 (2011)
36	2008	Estrogens and progesterone as neuroprotectants: what animal models teach us.	+	-	nl	Front Biosci 13(-):1083-9 (2008)
37	2011	Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries.	+	-	nl	Mol Med 17(5-6):448-56 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.